In a dramatic twist on the hit startup show Die Höhle der Löwen, former investor Diana zur Löwen returned to the spotlight—not to hand out deals, but to pitch for one. Together with co-founder Rebecca Linneweber and dentist Julia von Wolff, the 31-year-old entrepreneur stepped into the well-known arena to present their oral care brand, "Artem oral care."
However, the high-stakes pitch ended in disappointment when the founders left the studio without a single investor on board.
What Happened on the Show
Before beginning their pitch, zur Löwen briefly sat in one of the familiar investor chairs, joking that she wouldn't be stealing anyone's seat this time. The trio then pitched their specialized toothpaste duo designed for morning and evening use, which aims to combine oral health, microbiome balance, and aesthetics.
To fund the venture, the founders asked for 300,000 euros in exchange for a 10 percent stake in the company, valuing the startup at a hefty three million euros. With a premium price tag of 24.90 euros per tube, the product immediately caught the attention of the jury—and sparked immediate skepticism regarding its mass-market appeal.
Why the Deal Collapsed
While Ralf Dümmel and Frank Thelen had to recuse themselves due to competing investments in the dental and hygiene sector, the remaining sharks heavily scrutinized the business metrics. New investor Andreas W. Herb dismissed the pre-money valuation as "crazy," a sentiment quickly echoed by veteran investor Judith Williams.
Although Williams praised the entrepreneurial drive and the overall business concept, she firmly rejected the three-million-euro valuation for an early-stage product. In an effort to save the negotiation, the founders attempted a counter-offer of 400,000 euros for 20 percent equity—effectively lowering the valuation adjustment—but it failed to sway the room.
Williams ultimately pulled out, telling her former colleague: "Diana, I'll always be your friend. But I am not your investor based on your valuation." Janna Ensthaler also passed, leaving zur Löwen and her partners visibly disappointed as they exited the show empty-handed.
Why It Matters: Valuation Realities in the Shark Tank
This high-profile rejection highlights a recurring friction point on prime-time investor shows: the collision between influencer-driven marketing power and traditional financial fundamentals. While zur Löwen's massive social media reach provides immediate brand visibility and lower customer acquisition costs, the sharks ultimately evaluate companies based on current revenue multiples, unit economics, and scalable retail margins. A three-million-euro price tag for a niche oral care line without established retail distribution proved to be a bridge too far for the panel.
What's Next for Artem Oral Care
Walking away without an investor does not spell the end for the brand. Armed with high public awareness from the television broadcast and zur Löwen's digital platform, Artem oral care can continue pursuing direct-to-consumer sales independently. However, the founders will likely need to reevaluate their pricing strategy and valuation expectations if they seek institutional backing or retail partnerships in the future.
